Trevor M. PENNING,Adegoke ADENIJI,Lawrence J. MARNETT
申请号：
US15769565
公开号：
US20180305305A1
申请日:
2016.10.21
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention includes 2-β-naphthyl-acetic acid derivatives, which are selective AKR1C3 inhibitors. In certain embodiments, the compounds of the invention are (R)-naproxen analogs. The invention further includes methods of treating cancer, such as prostate cancer and/or castration-resistant prostate cancer, using at least one compound of the invention.
